Role of alcohol metabolism in non-alcoholic steatohepatitis

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Baker, Susan S ^a   Baker, Robert D ^a   Liu, Wensheng ^a   Nowak, Norma J ^a,b   Zhu, Lixin ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; APOLIPOPROTEIN A1; APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; BETA ACTIN; CATALASE; CD36 ANTIGEN; CD40 LIGAND; COLLAGEN TYPE 5; COLLAGEN TYPE 6; COLLAGEN TYPE 8; CXCL11 CHEMOKINE; CYTOCHROME P450 2E1; CYTOCHROME P450 3A5; FATTY ACID BINDING PROTEIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUTATHIONE TRANSFERASE A1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HISTONE H2A; HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; RETINOL BINDING PROTEIN 4; STROMAL CELL DERIVED FACTOR 1; TOLL LIKE RECEPTOR 4; UNINDEXED DRUG; VILLIN; ALCOHOL DEHYDROGENASE IV; ALCOHOL DERIVATIVE; AVP PROTEIN, HUMAN; NEUROPHYSIN; PROTEIN PRECURSOR; VASOPRESSIN DERIVATIVE;

ADOLESCENT; ADULT; ALCOHOL METABOLISM; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATITIS; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MALE; MICROARRAY ANALYSIS; NONALCOHOLIC FATTY LIVER; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; UNINDEXED SEQUENCE; WESTERN BLOTTING; DRINKING BEHAVIOR; FATTY LIVER; FIBROSIS; IMMUNOBLOTTING; INFLAMMATION; LIVER; METABOLISM; PATHOLOGY;

ANIMALIA; MUS;

ADOLESCENT; ALCOHOL DEHYDROGENASE; ALCOHOL DRINKING; ALCOHOLS; CHILD; CYTOCHROME P-450 CYP2E1; FATTY LIVER; FEMALE; FIBROSIS; HUMANS; IMMUNOBLOTTING; INFLAMMATION; LIVER; MALE; NEUROPHYSINS; PROTEIN PRECURSORS; VASOPRESSINS;

EID: 77949677097     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009570     Document Type: Article

References (35)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434-438.
2. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
3. Day CP, James OF (1998) Steatohepatitis: a tale of two "hits"? Gastroenterology 114: 842-845.
4. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, et al. (2001) Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120: 1183-1192.
5. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, et al. (2005) Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115: 1343-1351.
6. Gervois P, Fruchart JC, Staels B (2007) Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors. Nat Clin Pract Endocrinol Metab 3: 145-156.
7. Begriche K, Igoudjil A, Pessayre D, Fromenty B (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6: 1-28.
8. Parola M, Robino G (2001) Oxidative stress-related molecules and liver fibrosis. J Hepatol 35: 297-306.
9. Diehl AM, Goodman Z, Ishak KG (1988) Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95: 1056-1062.
10. Cope K, Risby T, Diehl AM (2000) Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119: 1340-1347.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
12. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321.
13. Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
14. Yokoyama S, Matsuo Y, Ramsbotham R, Yokoyama R (1994) Molecular characterization of a class IV human alcohol dehydrogenase gene (ADH7). FEBS Lett 351: 411-415.
15. Szabo G, Velayudham A, Romics L, Jr., Mandrekar P (2005) Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4. Alcohol Clin Exp Res 29: 140S-145S.
16. Kawaratani H, Tsujimoto T, Kitazawa T, Kitade M, Yoshiji H, et al. (2008) Innate immune reactivity of the liver in rats fed a choline-deficient L-aminoacid-defined diet. World J Gastroenterol 14: 6655-6661.
17. Yokoyama H, Baraona E, Lieber CS (1994) Molecular cloning of human class IV alcohol dehydrogenase cDNA. Biochem Biophys Res Commun 203: 219-224.
18. Lindinger W, Taucher J, Jordan A, Hansel A, Vogel W (1997) Endogenous production of methanol after the consumption of fruit. Alcohol Clin Exp Res 21: 939-943.
19. Baraona E, Julkunen R, Tannenbaum L, Lieber CS (1986) Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 90: 103-110.
20. Nosova T, Jokelainen K, Kaihovaara P, Jousimies-Somer H, Siitonen A, et al. (1996) Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestine. Alcohol Alcohol 31: 555-564.
21. Tsutsumi M, Lasker JM, Shimizu M, Rosman AS, Lieber CS (1989) The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10: 437-446.
22. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C (1998) Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27: 128-133.
23. Lieber CS, Schmid R (1961) The effect of ethanol on fatty acid metabolism; stimulation of hepatic fatty acid synthesis in vitro. J Clin Invest 40: 394-399.
24. Galli A, Price D, Crabb D (1999) High-level expression of rat class I alcohol dehydrogenase is sufficient for ethanol-induced fat accumulation in transduced HeLa cells. Hepatology 29: 1164-1170.
25. Bode C, Bode JC (2005) Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol? Alcohol Clin Exp Res 29: 166S-171S.
26. Mandrekar P, Catalano D, Szabo G (1999) Inhibition of lipopolysaccharide-mediated NFkappaB activation by ethanol in human monocytes. Int Immunol 11: 1781-1790.
27. Nelson S, Bagby G, Summer WR (1989) Alcohol suppresses lipopolysaccharide-induced tumor necrosis factor activity in serum and lung. Life Sci 44: 673-676.
28. McClain CJ, Cohen DA (1989) Increased tumor necrosis factor production by monocytes in alcoholic hepatitis. Hepatology 9: 349-351.
29. Honchel R, Ray MB, Marsano L, Cohen D, Lee E, et al. (1992) Tumor necrosis factor in alcohol enhanced endotoxin liver injury. Alcohol Clin Exp Res 16: 665-669.
30. Kishore R, Hill JR, McMullen MR, Frenkel J, Nagy LE (2002) ERK1/2 and Egr-1 contribute to increased TNF-alpha production in rat Kupffer cells after chronic ethanol feeding. Am J Physiol Gastrointest Liver Physiol 282: G6-15.
31. Shi L, Kishore R, McMullen MR, Nagy LE (2002) Chronic ethanol increases lipopolysaccharide-stimulated Egr-1 expression in RAW 264.7 macrophages: contribution to enhanced tumor necrosis factor alpha production. J Biol Chem 277: 14777-14785.
32. Zhang Z, Bagby GJ, Stoltz D, Oliver P, Schwarzenberger PO, et al. (2001) Prolonged ethanol treatment enhances lipopolysaccharide/phorbol myristate acetate-induced tumor necrosis factor-alpha production in human monocytic cells. Alcohol Clin Exp Res 25: 444-449.
33. Lieber CS (1999) Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998)-a review. Alcohol Clin Exp Res 23: 991-1007.
34. Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10: 2247-2258.
35. Zhang Z, Kolls JK, Oliver P, Good D, Schwarzenberger PO, et al. (2000) Activation of tumor necrosis factor-alpha-converting enzyme-mediated ectodomain shedding by nitric oxide. J Biol Chem 275: 15839-15844.